What is ELTP's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.25B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ELTP?

P/E (TTM) is 4.37 and 52-week range is $0.21 to $0.69 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ELTP figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ELTP?

The company profile lists revenue (TTM) near $135M, net income (TTM) near $54M, EPS (TTM) near $0.05 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Elite Pharmaceuticals Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Northvale, New Jersey, US, 1.08B shares outstanding, ISIN US28659T2006 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Elite Pharmaceuticals Inc

$ELTP

Health Care · Pharmaceuticals

IR Run Scenarios

Overview Charts AI Summary Financials Valuation

Profile

Read AI summary

Elite Pharmaceuticals, Inc. engages in the provision of development and manufacture of pharmacological abuse-deterrent opioid products. The company is headquartered in Northvale, New Jersey and currently employs 68 full-time employees. The company went IPO on 2014-02-20. The firm specializes in developing and manufacturing oral, controlled-release drug products. The company owns multiple generic products which has been licensed to Prasco, LLC and TAGI Pharma. The Company’s segments include Abbreviated New Drug Applications (ANDA) and New Drug Application (NDA). The Company’s products include Phentermine HCl 37.5mg tablets, Loxapine Succinate 5mg, 10mg, 25mg and 50gm capsules, Phentermine HCl 15mg and 30mg capsules, Naltrexone HCl 50mg tablets, Dantrolene Sodium Capsules 25mg, 50mg and 100mg, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Immediate Release 5mg, 7.5mg, 10mg, 12.5mg, 15mg, 20mg and 30mg tablets, Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, Amphetamine Sulfate Extended Release 5mg, 10mg, 15mg, 20mg, 25mg, and 30mg capsules and others.

Employees

Website

www.elitepharma.com/

IPO

2014-02-20

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

OTC MARKETS

ISIN

US28659T2006

Headquarters

Northvale, New Jersey, US

Shares outstanding

1.08B

NAICS sector

Manufacturing

Institutional ownership

0.00%

Browse other companiesFree AI scores and summaries for more stocks